Partnering & innovation

Science and innovation in the U.S.

Science and innovation in the U.S.

Novo Nordisk Research and Development (R&D) is dedicated to building on our 100-year heritage of putting patients first and collaborating for the future of innovative medicines. We have more than 600 scientists and engineers who develop and manage our R&D program around the world -- exploring novel and innovative treatments to address the unmet needs of people living with diabetes, obesity, hemophilia, growth hormone-related disorders and non-alcoholic steatohepatitis (NASH).

Celebrating 12 years as one of Fortune’s “100 Best Companies to Work For"

Our scientific approach

The pharmaceutical value chain

When it comes to innovative treatments and medical devices that improve lives, Novo Nordisk scientists and engineers work at the frontiers of discovery. Our pharmaceutical value chain helps us to get innovative treatments and devices into the hands of patients who need them.

Understanding the journey